MYGN MYRIAD GENETICS INC: institutional ownership and insider trading
210 funds reported holding $593M of MYRIAD GENETICS INC in their latest 13F filings; in Q2 2026 funds net bought $6.46M, with 43 new positions and 46 funds selling out; over the last 12 months insiders bought $722K and sold $66.9K on the open market; over its last four quarters it reported revenue of $807M and net income of −$113M.
MYGN revenue and earnings
- Quarter ended Jun 30, 2026: revenue $191M, net income −$43.2M, EPS -0.46
- Quarter ended Mar 31, 2026: revenue $200M, net income −$34.1M, EPS -0.36
- Quarter ended Dec 31, 2025: revenue $210M, net income −$8.00M, EPS -0.09
- Quarter ended Sep 30, 2025: revenue $206M, net income −$27.4M, EPS -0.29
Famous investors holding MYGN
- Izzy Englander (Millennium Management): $37.8M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $26.2M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $8.89M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $9.06M, 0.0% of the portfolio
Largest institutional holders of MYGN
- BlackRock, Inc. (BLK) — $62.2M
- VANGUARD GROUP INC — $50.6M
- MILLENNIUM MANAGEMENT LLC — $37.8M
- Vestal Point Capital, LP — $32.7M
- STATE STREET CORP (STT, STT-PG) — $28.5M
- D. E. Shaw & Co., Inc. — $26.2M
- VANGUARD CAPITAL MANAGEMENT LLC — $23.3M
- Nuveen Asset Management, LLC — $18.7M
- ACADIAN ASSET MANAGEMENT LLC — $17.8M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $17.6M
Recent MYGN insider trades
- Jun 8, 2026: Kumar Rashmi sold 15,000 shares ($66.9K)
- May 14, 2026: Bisaro Paul bought 7,500 shares ($27.7K)
- Mar 9, 2026: Raha Samraat S. bought 40,000 shares ($200K)
- Feb 27, 2026: Phanstiel S. Louise bought 104,507 shares ($495K)
5%+ owners
- BlackRock Portfolio Management LLC: 10.4% (Schedule 13G, filed Sep 4, 2026)
- BlackRock, Inc.: 8.5% (Schedule 13G/A, filed Apr 7, 2026)
- Vestal Point Capital, LP: 6.1% (Schedule 13G, filed Aug 14, 2026)
- STATE STREET CORPORATION: 5.3% (Schedule 13G, filed Aug 7, 2026)
Who owns the most MYGN stock?
The largest institutional holders of MYRIAD GENETICS INC in the latest 13F filings are BlackRock, Inc. (BLK) ($62.2M), VANGUARD GROUP INC ($50.6M), MILLENNIUM MANAGEMENT LLC ($37.8M).
Are insiders buying or selling MYGN?
Over the last 12 months insiders bought $722K and sold $66.9K of MYRIAD GENETICS INC stock on the open market (SEC Form 4).
Which famous investors own MYGN?
Izzy Englander, D. E. Shaw, Two Sigma, Ken Griffin.
What was MYGN's revenue last quarter?
MYRIAD GENETICS INC reported revenue of $191M for the quarter ended June 30, 2026, with net income of −$43.2M.
Which ETFs hold MYGN?
3 ETFs and mutual funds hold it among their top 100 positions, including VSFAX, DLHAX, GNOM.